Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford and Oxford University Hospitals NHS Foundation Trust (OUH) have won £113.7 million to support groundbreaking medical research.

Several images showing the breadth of research at NDORMS.

The Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) is leading two of the themes of the new NIHR Oxford Biomedical Research Centre (BRC), in Musculoskeletal sciences (Professor Andrew Carr) and Gastroenterology & Mucosal Immunity (Professor Fiona Powrie).

The National Institute for Health Research (NIHR), which is funded through the Department for Health, today announced that the Oxford BRC was one of 20 successful BRCs throughout England to receive funding for 2017 to 2022 following a competitive bidding process. NIHR BRCs bring together expertise within the NHS and leading research organisations to turn latest discoveries into fundamentally new treatments for patients.

The musculoskeletal theme now in the NIHR Oxford BRC replaces the current NIHR Oxford Musculoskeletal Biomedical Research Unit (BRU), to end in March 2017.

Professor Andrew Carr, Head of Department and theme lead on the new NIHR Oxford BRC, said: 'We are delighted to lead two themes in this successful NIHR Oxford BRC, building on the excellence of translational research of our NIHR Oxford BRU. The close working relationship between basic scientists and clinicians fostered by the BRC partnerships has already led to novel treatments and will continue to allow us to improve the lives of our patients.'

Musculoskeletal Theme

Our vision is to build on our established and proven strengths in the identification of therapeutic targets and to accelerate the translation of new personalized therapies in inflammatory joint disease, degenerative joint disorders and in rare bone diseases. We will also further develop and translate Oxford's promising tissue engineering implants and devices and regenerative medicine therapies for the benefit of patients.

Gastroenterology & Mucosal Immunity Theme

Inflammation underpins many common gastrointestinal tract and liver (GI) and skin diseases, such as inflammatory bowel disease (IBD), primary sclerosing cholangitis (PSC), non-alcoholic fatty liver disease (NAFLD), psoriasis and atopic dermatitis (AD) that are a significant source of morbidity and mortality. We envisage a new taxonomy of disease, based on molecular pathogenesis, to identify unique and common drivers of disease across GI and skin diseases. This will enable enhanced diagnosis and treatment strategies ensuring expensive immunotherapies with potential side effects are targeted to those patients most likely to benefit.

Similar stories

New hope for patients after vedolizumab found effective to treat Chronic Pouchitis

A new study led by Oxford researchers has found vedolizumab can induce remission in patients who have chronic pouchitis after surgery for ulcerative colitis.

New approach to nail bed injury surgery could significantly cut NHS costs

According to a new Oxford study, changing clinical practice for finger injuries in children could save the NHS £720,000 per year.

Furniss Group paper wins journal award

Editors at the Journal of Hand Surgery have recognised the Furniss Group with an award for the best paper published in the Journal in 2022. The Editor’s Award recognises research with scientific importance, outstanding study stringency, and a high academic standard.

NIHR Fellowships awarded to NDORMS researchers

Congratulations to Eileen Morrow and Mae Chester-Jones who have received NIHR Doctoral Fellowships

ORUK Early Career Research Fellowship awarded to NDORMS researcher

Congratulations to Jack Tu who has been awarded an Orthopaedic Research UK Early Career Research Fellowship to explore the cause of knee pain after total knee replacement.

OCTRU - delivering answers to important clinical questions

The Oxford Clinical Trials Research Unit (OCTRU) has received NIHR benchmarking results and offers excellent value for money according to the report